Theriva Biologics, Inc.
TOVX- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000894158
No open-market purchases or sales by Theriva Biologics, Inc. insiders were filed in the last 90 days; 26 institutions reported holding it in 13F filings for Q2 2026, worth $495.5K in total; no superinvestor holds it.
13F holders, Q3 2021
Institutional positions in Theriva Biologics, Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 36
- +5 vs. Q2 2021
- Shares held
- 7.23M
- +730.6K (+11.2%) vs. Q2 2021
- Total value
- $3.32M
- −$591.0K (−15.1%) vs. Q2 2021
- New holders
- 5
- 12 more added
- Sold out
- 0
- 3 more reduced
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TOVX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 26 | $495.5K |
| Q1 2026 | 22 | $385.4K |
| Q4 2025 | 21 | $272.4K |
| Q3 2025 | 20 | $177.0K |
| Q2 2025 | 17 | $126.3K |
| Q1 2025 | 11 | $209.8K |
| Q4 2024 | 10 | $60.3K |
| Q3 2024 | 18 | $678.6K |
| Q2 2024 | 22 | $327.6K |
| Q1 2024 | 24 | $366.3K |
| Q4 2023 | 24 | $452.3K |
| Q3 2023 | 21 | $572.8K |
| Q2 2023 | 18 | $1.01M |
| Q1 2023 | 19 | $724.6K |
| Q4 2022 | 22 | $477.1K |
| Q3 2022 | 26 | $1.15M |
| Q2 2022 | 33 | $2.51M |
| Q1 2022 | 35 | $3.17M |
| Q4 2021 | 35 | $3.24M |
| Q3 2021 | 36 | $3.32M |
| Q2 2021 | 31 | $3.91M |
| Q1 2021 | 32 | $5.80M |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding Theriva Biologics, Inc.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 2,014,798 | $925.0K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 1,876,909 | $863.0K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 976,316 | $448.0K | 0.00% | +20,035+2.1% | Added |
| State Street Corp | 471,920 | $217.0K | 0.00% | 00.0% | Unchanged |
| Gsa Capital Partners LLP | 275,240 | $126.0K | 0.01% | +275,240 | New |
| Northern Trust Corp | 245,399 | $113.0K | 0.00% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 213,075 | $98.0K | 0.00% | +191,300+878.5% | Added |
| Blair William & Co | 203,643 | $94.0K | 0.00% | +32,342+18.9% | Added |
| Virtu Financial LLC | 192,345 | $88.0K | 0.01% | −57,553−23.0% | Reduced |
| Two Sigma Advisers, LP | 128,300 | $59.0K | 0.00% | +94,600+280.7% | Added |
| Fisher Asset Management, LLC | 125,698 | $58.0K | 0.00% | 00.0% | Unchanged |
| MSD Partners, L.P. | 116,430 | $53.0K | 0.00% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 74,300 | $34.0K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 52,511 | $24.0K | 0.00% | +52,452+88,901.7% | Added |
| Citadel Advisors LLC | 43,708 | $20.0K | 0.00% | +33,125+313.0% | Added |
| Manufacturers Life Insurance Company, The | 23,577 | $11.0K | 0.00% | 00.0% | Unchanged |
| Sterneck Capital Management, LLC | 25,000 | $11.0K | 0.01% | 00.0% | Unchanged |
| Morgan Stanley | 21,084 | $10.0K | 0.00% | +20,833+8,300.0% | Added |
| Susquehanna International Group, LLP | 21,997 | $10.0K | 0.00% | +21,997 | New |
| Victory Capital Management Inc | 19,608 | $9.00K | 0.00% | −990−4.8% | Reduced |
| Jacobi Capital Management LLC | 18,500 | $9.00K | 0.00% | 00.0% | Unchanged |
| Clearview Wealth Advisors LLC | 20,418 | $9.00K | 0.01% | +2,009+10.9% | Added |
| Mercer Global Advisors Inc | 20,000 | $9.00K | 0.00% | +20,000 | New |
| Tower Research Capital LLC (TRC) | 13,260 | $6.00K | 0.00% | +10,557+390.6% | Added |
| HRT Financial LP | 13,855 | $6.00K | 0.00% | +13,855 | New |
| Creative Planning | 10,000 | $5.00K | 0.00% | 00.0% | Unchanged |
| Stratos Wealth Partners, LTD. | 10,000 | $5.00K | 0.00% | 00.0% | Unchanged |
| IFP Advisors, Inc | 3,825 | $3.00K | 0.00% | +50+1.3% | Added |
| Wells Fargo & Company | 809 | $0 | 0.00% | −40−4.7% | Reduced |
| BNP Paribas Arbitrage, SA | 1 | $0 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 733 | $0 | 0.00% | +612+505.8% | Added |
| Royal Bank of Canada | 187 | $0 | 0.00% | +115+159.7% | Added |
| Focused Wealth Management, Inc | 500 | $0 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 479 | $0 | 0.00% | 00.0% | Unchanged |
| Steward Partners Investment Advisory, LLC | 143 | $0 | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 47 | $0 | 0.00% | +47 | New |